Intravenous administration of piceatannol, an arginase inhibitor, improves endothelial dysfunction in aged mice

다국어 초록 (Multilingual Abstract)

Advanced age is one of the risk factors for vascular diseases that are mainly caused by impaired nitric oxide (NO) production. It has been demonstrated that endothelial arginase constrains the activity of endothelial nitric oxide synthase (eNOS) and limits NO generation. Hence, arginase inhibition is suggested to be vasoprotective in aging. In this study, we examined the effects of intravenous injection of Piceatannol, an arginase inhibitor, on aged mice. Our results show that Piceatannol administration reduced the blood pressure in aged mice by inhibiting arginase activity, which was associated with NO production and reactive oxygen species generation. In addition, Piceatannol administration recovered Ca2+/ calmodulin-dependent protein kinase II phosphorylation, eNOS phosphorylation and eNOS dimer stability in the aged mice. The improved NO signaling was shown to be effective in attenuating the phenylephrine-dependent contractile response and in enhancing the acetylcholine-dependent vasorelaxation response in aortic rings from the aged mice. These data suggest Piceatannol as a potential treatment for vascular disease.

참고문헌 (Reference)

1 Moon MK, "Vasodilatory and anti-inflammatory effects of the aqueous extract of rhubarb via a NO-cGMP pathway" 78 : 1550-1557, 2006

2 Barbato JE, "The emerging role of gene therapy in the treatment of cardiovascular diseases" 40 : 499-545, 2003

3 Moncada S, "The L-arginine-nitric oxide pathway" 329 : 2002-2012, 1993

4 Böger RH, "Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production" 117 : 273-284, 1995

5 Closs EI, "Substrate supply for nitric-oxide synthase in macrophages and endothelial cells : role of cationic amino acid transporters" 57 : 68-74, 2000

6 Simon A, "Role of neutral amino acid transport and protein breakdown for substrate supply of nitric oxide synthase in human endothelial cells" 93 : 813-820, 2003

7 Ainieng Woo, "Piceatannol-3'-O-β-D-glucopyranoside as an active component of rhubarb activates endothelial nitric oxide synthase through inhibition of arginase activity" 생화학분자생물학회 42 (42): 524-532, 2010

8 Choi KH, "Phosphoinositide 3-kinase is a novel target of piceatannol for inhibiting PDGF-BB-induced proliferation and migration in human aortic smooth muscle cells" 85 : 836-844, 2010

9 Milstien S, "Oxidation of tetrahydrobiopterin by peroxynitrite : implications for vascular endothelial function" 263 : 681-684, 1999

10 Takimoto E, "Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load" 115 : 1221-1231, 2005

11 Blum A, "Oral L-arginine in patients with coronary artery disease on medical management" 101 : 2160-2164, 2000

12 Kibbe MR, "Nitric oxide synthase gene therapy in vascular pathology" 24 : 51-54, 2000

13 Roger N, "Nitric oxide inhalation during exercise in chronic obstructive pulmonary disease" 156 : 800-806, 1997

14 Nisoli E, "Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals" 101 : 16507-16512, 2004

15 Katusic ZS, "Mechanisms of endothelial dysfunction induced by aging : role of arginase I" 101 : 640-641, 2007

16 Tran Minh Ngoc, "Lipoxygenase Inhibitory Constituents from Rhubarb" 대한약학회 31 (31): 598-605, 2008

17 Wilson AM, "L-arginine supplementation in peripheral arterial disease : no benefit and possible harm" 116 : 188-195, 2007

18 Dudek D, "L-arginine supplementation does not inhibit neointimal formation after coronary stenting in human beings: an intravascular ultrasound study" 147 : E12-, 2004

19 Böger RH, "L-Arginine therapy in cardiovascular pathologies:beneficial or dangerous?" 11 : 55-61, 2008

20 White AR, "Knockdown of arginase I restores NO signaling in the vasculature of old rats" 47 : 245-251, 2006

21 Griffiths MJ, "Inhaled nitric oxide therapy in adults" 353 : 2683-2695, 2005

22 Matsumoto A, "Inhaled nitric oxide and exercise capacity in congestive heart failure" 349 : 999-1000, 1997

23 Ichinose F, "Inhaled nitric oxide : a selective pulmonary vasodilator : current uses and therapeutic potential" 109 : 3106-3111, 2004

24 Woosung Shin, "Increased arginase II activity contributes to endothelial dysfunction through endothelial nitric oxide synthase uncoupling in aged mice" 생화학분자생물학회 44 (44): 594-602, 2012

25 Ansel GM, "Evolving modalities for femoropopliteal interventions" 16 : II82-II97, 2009

26 Walker HA, "Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in men with stable angina : lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance" 38 : 499-505, 2001

27 Cai H, "Endothelial dysfunction in cardiovascular diseases : the role of oxidant stress" 87 : 840-844, 2000

28 Ryoo S, "Endothelial arginase II : a novel target for the treatment of atherosclerosis" 102 : 923-932, 2008

29 Romero MJ, "Diabetes-induced coronary vascular dysfunction involves increased arginase activity" 102 : 95-102, 2008

30 Berkowitz DE, "Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels" 108 : 2000-2006, 2003

31 Steppan J, "Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism" 103 : 4759-4764, 2006

32 Woo A, "Arginase inhibition by piceatannol-3'-O-b-D-glucopyranoside improves endothelial dysfunction via activation of endothelial nitric oxide synthase in ApoE-null mice fed a high-cholesterol diet" 31 : 803-810, 2013

33 Erdely A, "Arginase activities and global arginine bioavailability in wild-type and ApoEdeficient mice: responses to high fat and high cholesterol diets" 5 : e15253-, 2010

34 Huynh NN, "Arginase II knockout mouse displays a hypertensive phenotype despite a decreased vasoconstrictory profile" 54 : 294-301, 2009

35 Matsuda H, "Antioxidant constituents from rhubarb : structural requirements of stilbenes for the activity and structures of two new anthraquinone glucosides" 9 : 41-50, 2001

36 Sang Zin Choi, "Antidiabetic Stilbene and Anthraquinone Derivatives from Rheum undulatum" 대한약학회 28 (28): 1027-1030, 2005

37 Seals DR, "Aging and vascular endothelial function in humans" 120 : 357-375, 2011